Cervarix


Also found in: Wikipedia.

Cervarix

A human papillomavirus vaccine.
References in periodicals archive ?
Latest data for England shows 84 per cent of girls aged 13 to 14 - representing the first year of the programme - have had all three doses of the Cervarix jab.
The most important facts for parents and/or older patients to know, several physicians said, is that both Gardasil and Cervarix protect against the two strains of HPV (types 16 and 18) that are believed to cause 70% of all cervical cancers, and that Gardasil also protects against HPV-6 and -11, the most common cause of genital warts.
In the UK, from September 2008 to July 2010, at least four million doses of the Cervarix jab were given.
Under pressure from medical institutions and charities, Glaxo Smith Kline, one of the two main vaccine manufacturers and producers of the Cervarix vaccine, have slashed global prices to better correspond with local real wages.
and Cervarix (GlaxoSmithKline plc), are available across the globe.
ONE dose of the human papillomavirus (HPV) vaccine Cervarix could prevent as many cases of cervical cancer as the current two- and three-dose schedules, a new study contends.
compared to all other vaccines given to females aged 6 to 29 years (the target group for HPV vaccines), Gardasil and Cervarix alone were associated with over 60% of all serious [adverse reactions] (including 63.
Thomas Breuer, Senior Vice-President and Lead Physician, GSK Vaccines, said We re delighted to receive approval for Cervarix as a 2-dose schedule.
Cervarix protects against HPV types 16 and 18, the highest-risk strains of HPV, and is approved for girls ages 9 to 26.
This comes at a time when the government have announced a switch from the current vaccine Cervarix, made by GlaxoSmithKline to Sanofi/MSD's Gardasil.
The Scottish Government said Cervarix, which protects against cervical cancer, is to be replaced with Gardasil.